{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:34:59Z","timestamp":1770896099031,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Takeda Development Center Americas, Inc., Lexington, MA","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hereditary angioedema (HAE), a rare autosomal dominant disorder characterized by recurrent, potentially life-threatening attacks of cutaneous or submucosal swelling, affects patients\u2019 everyday activities and psychological well-being. Although caregivers are instrumental in helping patients cope with HAE, its impact on the caregivers\u2019 quality of life is poorly documented. Using web-based surveys (July 2022\u2012February 2023), this international study (Argentina, Brazil, Colombia, Croatia, Denmark, Germany, Hungary, Ireland, Norway, Poland, Portugal, Romania, and Sweden) assessed the humanistic and psychosocial burden of caregivers (\u2265\u200918 years old) of pediatric (&lt;\u200918 years) and adult (\u2265\u200918 years) patients with diagnosed HAE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 120 caregivers completed the surveys: 54 caregivers of pediatric patients (CoPs; mean age 40.6 years; 79.6% female) and 66 caregivers of adult patients (CoAs; mean age 42.7 years; 48.5% female). CoPs and CoAs reported 5.6 and 13.1 HAE attacks (mean) in the past 6 months for individuals receiving their care, respectively. CoPs provided care for 23.5 days (mean) per month on average; in the past 4 weeks, CoPs missed (mean) 2.6 days (mean) of work, while the children missed 3.9 days (mean) of school. CoPs cited a lack of understanding of their caregiving duties from schools (20.4%), employers\/coworkers (16.7%), family (13.0%), friends (13.0%), and partner\/spouse (13.0%). CoPs reported impacts on their work (37.0%), sleep (37.0%), and household chores (31.5%), and restricted time with family (29.6%), spouses\/partners (27.8%), and friends (24.1%). Emotional impacts on the CoPs included worry about the child\u2019s health (90.7%) and future (68.5%); CoPs themselves reported having sleep problems (24.1%), migraine (22.2%), gastrointestinal disorders (22.2%), and anxiety (20.4%). CoAs reported impacts on their work (28.8%), sleep (28.8%), and recreational activities (27.3%), leading to missing time of work (mean 0.94 days in past 4 weeks). Emotional impacts on the CoAs included worry about the health of individual they provide care for (92.4%) and future (40.9%); CoAs themselves reported having anxiety (13.6%), migraines (13.6%), and sleep problems (12.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Results of this caregiver survey revealed that the caregiver role in HAE is time-demanding and adversely impacts various aspects of the caregiver\u2019s life, particularly their emotional wellbeing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04123-2","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:51:39Z","timestamp":1770893499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of hereditary angioedema: results from a multinational survey of caregivers for adult and pediatric patients"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-2625","authenticated-orcid":false,"given":"Maureen","family":"Watt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Martinez-Saguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Zwiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Sarrazola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete S.","family":"Grumach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"4123_CR1","first-page":"103","volume":"7","author":"A Ghazi","year":"2013","unstructured":"Ghazi A, Grant JA. Hereditary angioedema: epidemiology, management, and role of Icatibant. Biologics. 2013;7:103\u201313.","journal-title":"Biologics"},{"key":"4123_CR2","first-page":"S292","volume":"24","author":"JA Bernstein","year":"2018","unstructured":"Bernstein JA. Severity of hereditary angioedema, prevalence, and diagnostic considerations. Am J Manag Care. 2018;24:S292\u20138.","journal-title":"Am J Manag Care"},{"key":"4123_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","volume":"124","author":"A Banerji","year":"2020","unstructured":"Banerji A, Davis KH, Brown TM, Hollis K, Hunter SM, Long J, et al. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States. Ann Allergy Asthma Immunol. 2020;124:600\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"4123_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"K Bork","year":"2000","unstructured":"Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356:213\u20137.","journal-title":"Lancet"},{"key":"4123_CR5","doi-asserted-by":"crossref","unstructured":"Lumry WR, Settipane RA. Hereditary angioedema: epidemiology and burden of disease. Allergy Asthma Proc. 2020;41(Suppl 1):S08\u201313.","DOI":"10.2500\/aap.2020.41.200050"},{"key":"4123_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","volume":"13","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn E, Magerl M, Maetzel A, Maurer M. Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis. 2018;13:73.","journal-title":"Orphanet J Rare Dis"},{"key":"4123_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","volume":"119","author":"K Bork","year":"2006","unstructured":"Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267\u201374.","journal-title":"Am J Med"},{"key":"4123_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12016-021-08897-8","volume":"62","author":"FG Minafra","year":"2022","unstructured":"Minafra FG, Gon\u00e7alves TR, Alves TM, Pinto JA. The mortality from hereditary angioedema worldwide: a review of the real-world data literature. Clin Rev Allergy Immunol. 2022;62:232\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"4123_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.12968\/hmed.2019.80.7.391","volume":"80","author":"HJ Longhurst","year":"2019","unstructured":"Longhurst HJ, Bork K. Hereditary angioedema: an update on causes, manifestations and treatment. Br J Hosp Med (Lond). 2019;80:391\u20138.","journal-title":"Br J Hosp Med (Lond)"},{"key":"4123_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2500\/ajra.2011.25.3661","volume":"25","author":"BL Zuraw","year":"2011","unstructured":"Zuraw BL, Christiansen SC. Pathophysiology of hereditary angioedema. Am J Rhinol Allergy. 2011;25:373\u20138.","journal-title":"Am J Rhinol Allergy"},{"key":"4123_CR11","doi-asserted-by":"crossref","unstructured":"Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, et al. US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021;9:132\u2009\u2013\u200950.e3.","DOI":"10.1016\/j.jaip.2020.08.046"},{"key":"4123_CR12","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","volume":"77","author":"M Maurer","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Ayg\u00f6ren-P\u00fcrs\u00fcn E, et al. The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022;77:1961\u201390.","journal-title":"Allergy"},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13023-021-01717-4","volume":"16","author":"J Mendivil","year":"2021","unstructured":"Mendivil J, Murphy R, de la Cruz M, Janssen E, Boysen HB, Jain G, et al. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey. Orphanet J Rare Dis. 2021;16:94.","journal-title":"Orphanet J Rare Dis"},{"key":"4123_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.anai.2013.05.028","volume":"112","author":"AS Fouche","year":"2014","unstructured":"Fouche AS, Saunders EF, Craig T. Depression and anxiety in patients with hereditary angioedema. Ann Allergy Asthma Immunol. 2014;112:371\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"4123_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.iac.2017.04.005","volume":"37","author":"T Caballero","year":"2017","unstructured":"Caballero T, Prior N. Burden of illness and quality-of-life measures in angioedema conditions. Immunol Allergy Clin North Am. 2017;37:597\u2013616.","journal-title":"Immunol Allergy Clin North Am"},{"key":"4123_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.anai.2013.08.019","volume":"111","author":"A Banerji","year":"2013","unstructured":"Banerji A. The burden of illness in patients with hereditary angioedema. Ann Allergy Asthma Immunol. 2013;111:329\u201336.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"4123_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2340\/00015555-2014","volume":"95","author":"A Bygum","year":"2015","unstructured":"Bygum A, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Beusterien K, Hautamaki E, Sisic Z, Wait S, et al. Burden of illness in hereditary angioedema: a conceptual model. Acta Derm Venereol. 2015;95:706\u201310.","journal-title":"Acta Derm Venereol"},{"key":"4123_CR18","doi-asserted-by":"crossref","unstructured":"Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31:407\u2009\u2013\u200914.","DOI":"10.2500\/aap.2010.31.3394"},{"key":"4123_CR19","doi-asserted-by":"crossref","unstructured":"Caballero T, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, et al. The humanistic burden of hereditary angioedema: results from the burden of illness study in Europe. Allergy Asthma Proc. 2014;35:47\u201353.","DOI":"10.2500\/aap.2013.34.3685"},{"key":"4123_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1054773818780102","volume":"29","author":"J Granero-Molina","year":"2020","unstructured":"Granero-Molina J, S\u00e1nchez-Hern\u00e1ndez F, Fern\u00e1ndez-Sola C, Jim\u00e9nez-Lasserrotte MDM, Antequera-Raynal LH, Hern\u00e1ndez-Padilla JM. The diagnosis of hereditary angioedema: family caregivers\u2019 experiences. Clin Nurs Res. 2020;29:117\u201326.","journal-title":"Clin Nurs Res"},{"key":"4123_CR21","doi-asserted-by":"crossref","unstructured":"Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104:314\u2009\u2013\u200920.e2.","DOI":"10.1016\/j.anai.2010.01.024"},{"key":"4123_CR22","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.waojou.2023.100792","volume":"16","author":"J Raasch","year":"2023","unstructured":"Raasch J, Glaum MC, O\u2019Connor M. The multifactorial impact of receiving a hereditary angioedema diagnosis. World Allergy Organ J. 2023;16:100792.","journal-title":"World Allergy Organ J"},{"key":"4123_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fmed.2018.00022","volume":"5","author":"WR Lumry","year":"2018","unstructured":"Lumry WR. Hereditary angioedema: the economics of treatment of an orphan disease. Front Med (Lausanne). 2018;5:22.","journal-title":"Front Med (Lausanne)"},{"key":"4123_CR24","doi-asserted-by":"crossref","unstructured":"Craig TJ, Banerji A, Riedl MA, Best JM, Rosselli J, Hahn R, et al. Caregivers\u2019 role in managing hereditary angioedema and perceptions of treatment-related burden. Allergy Asthma Proc. 2021;42(Suppl 1):S11-6.","DOI":"10.2500\/aap.2021.42.210029"},{"key":"4123_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/all.12007","volume":"67","author":"K Weller","year":"2012","unstructured":"Weller K, Groffik A, Magerl M, Tohme N, Martus P, Krause K, et al. Development and construct validation of the Angioedema Quality of Life Questionnaire. Allergy. 2012;67:1289\u201398.","journal-title":"Allergy"},{"key":"4123_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/all.14144","volume":"75","author":"K Weller","year":"2020","unstructured":"Weller K, Donoso T, Magerl M, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Staubach P, Martinez-Saguer I, et al. Development of the Angioedema Control Test\u2014a patient-reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy. 2020;75:1165\u201377.","journal-title":"Allergy"},{"key":"4123_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353\u201365.","journal-title":"PharmacoEconomics"},{"key":"4123_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr., Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333.","journal-title":"Med Care"},{"key":"4123_CR29","volume-title":"SF-12: how to score the SF-12 physical and mental health summary scales","author":"JE Ware","year":"1998","unstructured":"Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. Boston: The Health Institute, New England Medical Center; 1998."},{"key":"4123_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12955-019-1229-3","volume":"17","author":"K Kulthanan","year":"2019","unstructured":"Kulthanan K, Chularojanamontri L, Rujitharanawong C, Weerasubpong P, Maurer M, Weller K. Angioedema Quality of Life Questionnaire (AE-QoL) - interpretability and sensitivity to change. Health Qual Life Outcomes. 2019;17:160.","journal-title":"Health Qual Life Outcomes"},{"key":"4123_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jaip.2020.02.038","volume":"8","author":"K Weller","year":"2020","unstructured":"Weller K, Donoso T, Magerl M, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Staubach P, Martinez-Saguer I, et al. Validation of the Angioedema Control Test (AECT)\u2014a patient-reported outcome instrument for assessing angioedema control. J Allergy Clin Immunol Pract. 2020;8:2050\u20137. e4.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4123_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13023-022-02260-6","volume":"17","author":"LM Ward","year":"2022","unstructured":"Ward LM, Chambers A, Mechichi E, Wong-Rieger D, Campbell C. An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries. Orphanet J Rare Dis. 2022;17:113.","journal-title":"Orphanet J Rare Dis"},{"key":"4123_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13023-025-03739-8","volume":"20","author":"T Buttgereit","year":"2025","unstructured":"Buttgereit T, Aulenbacher F, Adatia A, Ayala CV, Al-Nesf MA, Altrichter S, et al. Unmet needs in hereditary angioedema: an international survey of physicians. Orphanet J Rare Dis. 2025;20:383.","journal-title":"Orphanet J Rare Dis"},{"key":"4123_CR34","unstructured":"HAEi. Global Perspectives. HAEi Magazine. 2021;September."},{"key":"4123_CR35","unstructured":"HSE.ie. Medicines Management Programme Managed Access Protocol \u2013 Medicines for routine prevention of recurrent attacks of hereditary angioedema. 2024. https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/medicines-management\/managed-access-protocols\/lanadelumab-takhzyro-\/hse-managed-access-protocol-medicines-for-hereditary-angioedema.pdf. Accessed 11 August 2025."},{"key":"4123_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1750-1172-9-99","volume":"9","author":"E Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2014","unstructured":"Ayg\u00f6ren-P\u00fcrs\u00fcn E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S, et al. Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis. 2014;9:99.","journal-title":"Orphanet J Rare Dis"},{"key":"4123_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/mpr.145","volume":"12","author":"P Bech","year":"2003","unstructured":"Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-Five well-being scale. Int J Methods Psychiatr Res. 2003;12:85\u201391.","journal-title":"Int J Methods Psychiatr Res"},{"key":"4123_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp CW, \u00d8stergaard SD, S\u00f8ndergaard S, Bech P. The WHO-5 Well-Being index: a systematic review of the literature. Psychother Psychosom. 2015;84:167\u201376.","journal-title":"Psychother Psychosom"},{"key":"4123_CR39","doi-asserted-by":"crossref","unstructured":"Maurer M, Lumry WR, Li HH, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Busse PJ, Jacobs J, et al. Lanadelumab in patients 2 to less than 12 years old with hereditary angioedema: results from the phase 3 SPRING study. J Allergy Clin Immunol Pract. 2024;12:201\u2009\u2013\u200911.e6.","DOI":"10.1016\/j.jaip.2023.09.009"},{"key":"4123_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12529-022-10104-7","volume":"30","author":"AM Snyder","year":"2023","unstructured":"Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, et al. Quality of life among family of patients with atopic dermatitis and psoriasis. Int J Behav Med. 2023;30:409\u201315.","journal-title":"Int J Behav Med"},{"key":"4123_CR41","doi-asserted-by":"publisher","first-page":"987892","DOI":"10.3389\/fpsyt.2022.987892","volume":"13","author":"Z Yu","year":"2022","unstructured":"Yu Z, Shao Q, Hou K, Wang Y, Sun X. The experiences of caregivers of children with epilepsy: A meta-synthesis of qualitative research studies. Front Psychiatry. 2022;13:987892.","journal-title":"Front Psychiatry"},{"key":"4123_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s40359-024-01678-w","volume":"12","author":"M Ponzio","year":"2024","unstructured":"Ponzio M, Tacchino A, Verri A, Battaglia MA, Brichetto G, Podda J. Profile and burden of the family caregiver: the caring experience in multiple sclerosis. An observational study. BMC Psychol. 2024;12:173.","journal-title":"BMC Psychol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04123-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04123-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04123-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:51:50Z","timestamp":1770893510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04123-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04123-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board or Ethics Committee approval was obtained before recruitment and data collection for each site or country (both central and local ethics committee approval was required in Brazil, Croatia and Germany). This study was conducted in accordance with the protocol, the Declaration of Helsinki, Good Pharmacoepidemiology Practices, International Society of Pharmacoepidemiology guidelines for Good Pharmacoepidemiology Practices, and local regulations. All participants provided informed consent before recruitment and data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"MW and AS are employees of Takeda Development Center Americas, Inc. and hold stock\/options in Takeda Pharmaceutical Company Limited. IMS has received research funding support and\/or speaker\/consultant fees from BioCryst, CSL Behring, KalVista Pharmaceuticals, Octapharma, Pharming, Pharvaris and Takeda\/Shire. RM and MDLC are employees of ICON, which was contracted by Takeda to perform this study. RZ reports being a speaker for CSL Behring, Novartis, Pint Pharma, Sanofi, and Takeda; an advisor for AbbVie, CSL Behring, KalVista Pharmaceuticals, Pint Pharma, and Takeda; and a researcher for Sanofi and Takeda. MS was contracted by Takeda to conduct this study. ASG has received speaker\/consultancy fees from Astra Zeneca, Astria, Catalyst, CSL Behring, KalVista Pharmaceuticals, Multicare Pharma, Pharvaris, Pint Pharma, and Takeda; a scholarship from Brazilian Council of Research (CNPq); and a grant of researcher initiative from Takeda.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}